Posts tagged Maxim


MannKind Corporation (MNKD) Shares Slide as Maxim Heads to Sidelines

MannKind’s capital raise is not enough, says Jason Kolbert.

Read more

What’s Holding Back MannKind Corporation’s (MNKD) Valuation? Maxim Sees a Company Poised for Growth

Analyst says MannKind’s Afrezza revenues can surpass debt, if investors can be patient for adoption.

Read more

Helios and Matheson Analytics Inc’s (HMNY) Many Monetization Ways Have Attracted a New Bull

Maxim is confident that HMNY’s recent 52% purchase of MoviePass will usher in commercial leverage.

Read more

Maxim: Apple Inc. (AAPL) to Post Well Above Consensus EPS Results, Nutanix Inc (NTNX) Is Addressing a $22B Operating Profit Opportunity

Just before the weekend hits, Maxim’s Nehal Chokshi shares thoughts on his top tech picks: AAPL and NTNX.

Read more

Is New Teva Pharmaceutical Industries Ltd (ADR) (TEVA) CEO Walking into a Landmine? Oppenheimer and Maxim Weigh In

Here’s why analysts are playing it cautiously optimistic on the struggling pharmaceutical giant.

Read more

Why Maxim Raised Price Target for Adamis Pharmaceuticals Corp

Adamis Stock Can Reach $13 as Symjepi Deal Is Imminent

Read more

Maxim Initiates Buy on Diagnostics Group Inc (IDXG); Sees 410% Upside for the Stock

Analyst Jason Kolbert of Maxim believes that Interpace Diagnostics Group Inc (NASDAQ:IDXG) has quite the …

Read more

Maxim Sees Over 200% Upside for MannKind Corporation (MNKD)

  Shares of MannKind Corporation (NASDAQ:MNKD) are up nearly 3% in Friday trading session, as …

Read more

Is Teva Pharmaceutical Industries Ltd (ADR) (TEVA) at Rock Bottom? Maxim Weighs in

Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) released a grim second quarter print last Thursday, revealing …

Read more

AEterna Zentaris Inc. (USA) (AEZS) CEO’s Departure Raises Questions

AEterna Zentaris Inc. (USA) (NASDAQ:AEZS) shares are tumbling nearly 7% in Monday’s trading session, following …

Read more